Prognostic Comparison between cTACE and H101-TACE in Unresectable Hepatocellular Carcinoma (HCC): A Propensity-Score Matching Analysis.

Yao, Man; Cheng, Simo; Zhai, Xiaofeng; Zhao, Hetong; Hong, Jing; Li, Xiaoyan; Meng, Yongbin; Chen, Wei

Yao, Man; Cheng, Simo; Zhai, Xiaofeng; Zhao, Hetong; Hong, Jing; Li, Xiaoyan; Meng, Yongbin; Chen, Wei.

Afiliação

Yao M; Department of Integrative Oncology, The First Affiliated Hospital of Navy Military Medical University, Shanghai 200433, China.
Cheng S; School of Traditional Chinese Medicine, Navy Medical University, Shanghai 200433, China.
Zhai X; Department of Integrative Oncology, The First Affiliated Hospital of Navy Military Medical University, Shanghai 200433, China.
Zhao H; School of Traditional Chinese Medicine, Navy Medical University, Shanghai 200433, China.
Hong J; Department of Radiology, The First Affiliated Hospital of Navy Military Medical University, Shanghai 200433, China.
Li X; Department of Integrative Oncology, The First Affiliated Hospital of Navy Military Medical University, Shanghai 200433, China.
Meng Y; Department of Integrative Oncology, The First Affiliated Hospital of Navy Military Medical University, Shanghai 200433, China.
Chen W; Department of Radiology, The First Affiliated Hospital of Navy Military Medical University, Shanghai 200433, China.

Appl Bionics Biomech ; 2022: 9084852, 2022.

Article em En | MEDLINE | ID: mdl-36091626

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Appl Bionics Biomech Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google